Bronchus-associated lymphoid tissue lymphomas

Southern Medical Journal

Volumn 102, Issue 12, 2009, Pages 1229-1233

  Arnaoutakis, Konstantinos ^a   Oo, Thein H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BALT; Bronchus associated lymphoid tissue; Lymphoma

Indexed keywords

CHLORAMBUCIL; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BICLONAL IMMUNOGLOBULINEMIA; BONE MARROW BIOPSY; BRONCHIECTASIS; BRONCHUS ASSOCIATED LYMPHOID TISSUE LYMPHOMA; BRONCHUS CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; FATIGUE; FEMALE; GAMMOPATHY; HEMOPTYSIS; HUMAN; LYMPHATIC SYSTEM DISEASE; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; OPEN LUNG BIOPSY; OUTCOME ASSESSMENT; PATHOGENESIS; PROGNOSIS; REMISSION; SEROLOGY; SURVIVAL TIME; THORAX RADIOGRAPHY; TREATMENT INDICATION; TREATMENT RESPONSE; WEIGHT REDUCTION; BRONCHUS TUMOR; CANCER STAGING; CASE REPORT; IMMUNOTHERAPY; MARGINAL ZONE LYMPHOMA; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRONCHIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOTHERAPY; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 73949115320     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181bfdd2d     Document Type: Article

References (21)

1. Kocks JR, Davalos-Misslitz AC, Hintzen G, et al. Regulatory T cells interfere with the development of bronchus-associated lymphoid tissue. J Exp Med 2007;204:723-734.
2. Escolar Castellón JD, Escolar Castellón A, Roche Roche PA, et al. Bronchial-associated lymphoid tissue (BALT) response to airway challenge with cigarette smoke, bovine antigen and anti-pulmonary serum. Histol Histopathol 1992;7:321-328.
3. Rangel-Moreno J, Hartson L, Navarro C, et al. Inducible bronchusassociated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116:3183-3194.
4. Zucca E, Bertoni F, Stathis A, et al. Marginal zone lymphomas. Hematol Oncol Clin North Am 2008;22:883-901, viii.
5. Inadome Y, Ikezawa T, Oyasu R, et al. Malignant lymphoma of bronchus-associated lymphoid tissue coexistent with pulmonary tuberculosis. Pathol Int 2001;51:807-811.
6. Richmond I, Pritchard GE, Ashcroft T, et al. Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. Thorax 1993;48:1130-1134.
7. Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 2007;28:369-378.
8. Zinzani PL, Poletti V, Zompatori M, et al. Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma. Clin Lymphoma Myeloma 2007;7:566-572.
9. Takino H, Okabe M, Li C, et al. p16/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis. Mod Pathol 2005;18:1187-1192.
10. Remstein ED, Kurtin PJ, Einerson RR, et al. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia 2004;18:156-160.
11. Chng WJ, Remstein ED, Fonseca R, et al. Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications. Blood 2009;113:635-645.
12. Ahmed S, Kussick SJ, Siddiqui AK, et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004;40:1320-1326.
13. Isaacson PG, Muller-Hermelink, Piris MA, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma, in Jaffe ES, Harris NL, Stein H, Vardiman JW, (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2001, pp 157-160.
14. Wislez M, Cadranel J, Antoine M, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations. Eur Respir J 1999;14:423-429.
15. Takamori M, Noma S, Kobashi Y, et al. CT findings of BALTOMA. Radiat Med 1999;17:349-354.
16. Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J 2002;20:750-762.
17. Arkenau HT, Gordon C, Cunningham D, et al. Mucosa associated lymphoid tissue of the lung: the Royal Marsden Hospital experience. Leuk Lymphoma 2007;48:547-550.
18. Perceau G, Diris N, Estines O, et al. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 2006;155:1053-1056.
19. Suzan F, Ammor M, Ribrag V. Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. N Engl J Med 2001;345:1000.
20. Teichmann LL, Woenckhaus M, Vogel C, et al. Fatal pneumocystis pneumonia following rituximab administration for rheumatoid arthritis. Rheumatology (Oxford) 2008;47:1256-1257.
21. Kim JH, Lee SH, Park J. Primary pulmonary non-Hodgkin's lymphoma. Jpn J Clin Oncol 2004;34:510-514.